ProShares Trust - ProShares UltraShort Dow 30-2X Shares
DXD
Market Cap$26.94M
Close$
Share Statistics
| Market cap | $26.94 Million |
|---|---|
| Enterprise Value | $33.20 Million |
| Dividend Yield | $1.57192 (5.934012835032091%) |
| Earnings per Share | $- |
| Beta | -1.82 |
| Outstanding Shares | - |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.65 |
| Enterprise Value to EBIT | -3.9 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.4 |
| Debt to Equity | 0.64 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About BioAge Labs, Inc.
62 employees
CEO: Dr. Kristen Fortney Ph.D. BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets bas...